IRT Trademark

Trademark Overview


On Friday, October 23, 1998, a trademark application was filed for IRT with the United States Patent and Trademark Office. The USPTO has given the IRT trademark a serial number of 75576866. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Tuesday, February 8, 2000. This trademark is owned by AltaRex Corp.. The IRT trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

cancer therapy, namely, the use of mono clonal antibodies and radioisotopes in humans to combine the therapeutic effects of the mono clonal antibody and radioisotopes

General Information


Serial Number75576866
Word MarkIRT
Filing DateFriday, October 23, 1998
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateTuesday, February 8, 2000
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and Servicescancer therapy, namely, the use of mono clonal antibodies and radioisotopes in humans to combine the therapeutic effects of the mono clonal antibody and radioisotopes

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, December 21, 1998
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAltaRex Corp.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressEdmonton, Alberta T6G 2E1
CA

Trademark Events


Event DateEvent Description
Tuesday, February 8, 2000ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Tuesday, May 18, 1999NON-FINAL ACTION MAILED
Thursday, May 6, 1999ASSIGNED TO EXAMINER
Tuesday, April 27, 1999ASSIGNED TO EXAMINER